Please press here for Result of the General Meeting held on 28 March 2022

Please note the following in relation to the upcoming General Meeting on 26 November 2020:

(i) the entitlement time and date is 18:30 p.m. on 24 November 2020 (please ignore the typographical error in note 11 to the Notice of General Meeting which references 6 November 2020),

(ii) Proxy forms should be received by 24 November 2020. For the avoidance of doubt, any proxy forms received up to 10.00 a.m. on 25 November 2020 will also be valid.

Circular to shareholders dated 10 November 2020

Form of Proxy

Open Offer Application Form

Destiny Pharma to acquire Phase 3 ready C.difficile program and announces fund raising.  For full release please press here

Destiny Pharma is attending the 4th AMR Conference: Novel Antimicrobials and AMR Diagnostics on 12 – 13 March 2020, in Basel, Switzerland

If you would like to meet with Destiny Pharma, please email us on conferences@destinypharma.com

Destiny Pharma is attending the Infection Control 2020 conference on 13 February 2020, in Birmingham, UK

If you would like to meet with Destiny Pharma, please email us on conferences@destinypharma.com